Considering Context-Specific microRNAs in Ischemic Stroke with Three "W": Where, When, and What

Area of Science:

• Biochemistry
• Molecular Biology
• Neuroscience

Background:

• MicroRNAs (miRNAs) are key post-transcriptional gene regulators.
• Emerging evidence suggests miRNAs are potential biomarkers for ischemic stroke.
• Understanding miRNA biogenesis and transport is crucial for biomarker development.

Purpose of the Study:

• To review the role of microRNAs in ischemic stroke pathogenesis.
• To discuss promising microRNA biomarkers in ischemic stroke.
• To explore challenges and future directions for miRNA biomarker research.

Main Methods:

• Literature review on microRNA function, biogenesis, and transport.
• Analysis of microRNA biomarkers in ischemic stroke based on biofluid selection, timing of collection, and clinical application.
• Discussion of diagnostic, prognostic, and therapeutic potential of microRNAs.

Main Results:

• MicroRNAs play a role in ischemic stroke pathophysiology.
• Specific microRNAs show potential as biomarkers for diagnosis, risk stratification, and prognosis.
• MicroRNAs can aid in monitoring treatment response and classifying stroke subtypes.

Conclusions:

• MicroRNAs hold significant potential as clinical biomarkers for ischemic stroke.
• Overcoming current obstacles in research is essential for clinical translation.
• Developing microRNA panels is a promising avenue for improving ischemic stroke management.